Quick Takeaways
- Jason Drew Smith has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $1,094,527.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jason Drew Smith
- Location
- Princeton, NJ
- Summary
- The estimated net worth of Jason Drew Smith is at least $1,094,527 dollars as of 11 Feb 2026. Jason Drew Smith is the General Counsel of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $1.09M.
- Signature
- /s/ Jason D. Smith, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jason Drew Smith and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: UroGen Pharma Ltd. ($1,094,527).
- Past-year value change for that position: -$320,280.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jason Drew Smith
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | General Counsel | $1,094,527 | -$320,280 | -23% | 31 Jan 2026 |
Insider Transactions Reported by Jason Drew Smith:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.